Tilmann Bochtler
Expertise in
3
conditions

Tilmann Bochtler

Heidelberg, BW, DE 
Expertise in
3
conditions
Heidelberg, BW, DE 

Overview

Tilmann Bochtler practices practicing medicine in Heidelberg, Germany.

Bochtler is highly rated in 3 conditions, according to our data. Their clinical expertise encompasses Acute Myeloid Leukemia (AML), Primary Amyloidosis, Leukemia, Acute Promyelocytic Leukemia, and Bone Marrow Transplant.

They are actively involved in clinical research, co-authoring 64 peer reviewed articles and participating in 2 clinical trials.

Locations

Heidelberg, BW, Germany
Other Locations
Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Randomised Trial on Allogeneic Haematopoietic Stem Cell Transplantation in Patients Under the Age of 60 Years With Acute Myeloid Leukemia of Intermediate Risk in First Complete Remission and a Matched Sibling or Unrelated Donor (ETAL-1)
Randomised Trial on Allogeneic Haematopoietic Stem Cell Transplantation in Patients Under the Age of 60 Years With Acute Myeloid Leukemia of Intermediate Risk in First Complete Remission and a Matched Sibling or Unrelated Donor (ETAL-1)
Enrollment Status: Terminated
Publish Date: October 29, 2021
Intervention Type: Biological, Drug
Study Phase: Phase 3
Phase I/II Study of Sensitization of Non-M3 Acute Myeloid Leukemia (AML) Blasts to All-trans Retinoic Acid (ATRA) by Epigenetic Treatment With Tranylcypromine (TCP), an Inhibitor of the Histone Lysine Demethylase 1 (LSD1)
Phase I/II Study of Sensitization of Non-M3 Acute Myeloid Leukemia (AML) Blasts to All-trans Retinoic Acid (ATRA) by Epigenetic Treatment With Tranylcypromine (TCP), an Inhibitor of the Histone Lysine Demethylase 1 (LSD1)
Enrollment Status: Unknown
Publish Date: October 18, 2018
Intervention Type: Drug
Study Drugs: Tranylcypromine, All-Trans Retinoic Acid, Cytarabine
Study Phase: Phase 1/Phase 2
View 1 Less Clinical Trial

64 Total Publications

Molecularly Guided Therapy Versus Continued Chemotherapy in Unfavorable Cancer of Unknown Primary: Updated Efficacy and Safety From the Randomized, Phase II CUPISCO Study.
Molecularly Guided Therapy Versus Continued Chemotherapy in Unfavorable Cancer of Unknown Primary: Updated Efficacy and Safety From the Randomized, Phase II CUPISCO Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 03, 2026

Frequently Asked Questions about Tilmann Bochtler

Is Tilmann Bochtler a top-rated expert for Acute Myeloid Leukemia (AML)?

MediFind is an objective health platform that identifies experts based on real-world data. Tilmann Bochtler is classified as an Advanced expert for Acute Myeloid Leukemia (AML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Tilmann Bochtler participate in research or clinical trials?

Yes. Tilmann Bochtler has published 64 articles and abstracts on conditions like Acute Myeloid Leukemia (AML). You can view a list of Tilmann Bochtler's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Bochtler's expertise for a condition
ConditionClose
      View All 9 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile